Topic: Structural Heart

  Critical care comprises nearly 20% of Edwards’ revenue. Its continued growth is connected to […]

Dive Brief: A short, single-arm trial has generated evidence that transcatheter aortic valve replacement is […]

Boston Scientific (NYSE:BSX) announced today that it began a controlled launch of its Acurate neo2 aortic […]

  Researchers published a paper in the Journal of the American Medical Association citing insufficient evidence […]

Dive Brief: Medtronic on Wednesday simultaneously announced FDA breakthrough device designation and kickoff of an early […]

San Ramon, CA-based BioVentrix is developing a hybrid transcatheter device for left ventricular remodeling after […]

Medtronic (NYSE:MDT) announced last week that it received FDA approval for revised commercial labeling on its […]

Neovasc (NSDQ:NVCN) announced today that it agreed to sell shares of its common stock in a […]

Stroke prevention technology developer Conformal Medical filed an SEC Form D to confirm the sale of $70 […]

Confluent Medical this week announced it has opened a Complex Catheter Design and Development Center […]

Abiomed (NSDQ:ABMD) announced today that the FDA issued emergency use authorization (EUA) for its Impella heart […]

Dive Brief: Edwards Lifesciences raised expectations for 2020 transcatheter aortic valve replacement (TAVR) sales in a […]

Edwards Lifesciences (NYSE:EW) stock has jumped in after-hours trading after the company reported Street-beating Q2 results […]

Boston Scientific has won a nod from FDA for the latest generation of the Watchman […]

The FDA has approved the next-generation of Boston Scientific’s (NYSE:BSX) Watchman left atrial appendage closure (LAAC) device, […]

LivaNova is launching the Perceval Plus sutureless surgical aortic heart valve in Europe. The news […]

Edwards Lifesciences won FDA approval for its KONECT RESILIA aortic valved conduit, a device designed […]

Dive Brief: Edwards Lifesciences has agreed to pay Abbott $368 million upfront to settle disputes […]

Abiomed (NSDQ:ABMD) says a study of U.S. patients receiving the new Impella 5.5 with SmartAssist found […]

Dive Brief: The Centers for Medicare and Medicaid Services has proposed expanding coverage of transcatheter […]

Dive Brief: Polares Medical has raised $40 million to pursue a fast-growing cardiovascular opportunity targeted […]

Abbott (NYSE:ABT) today announced late-breaking data on some of its structural heart disease products. The data […]

Medtronic has received CE mark for an expanded indication of its Evolut Transcatheter Aortic Valve […]

Dive Brief: Medtronic’s Evolut transcatheter aortic valve implantation system now has an expanded CE mark […]

Medtronic (NYSE:MDT) announced today that it received CE Mark approval for its Evolut transcatheter aortic valve […]

Heart valve designer and manufacturer Foldax announced today that it closed a Series D funding round with […]

CryoLife Inc. (NYSE:CRY) announced today that it intends to offer a private placement of convertible senior […]

Edwards Lifesciences (NYSE:EW) announced today that it received regulatory approval in China for its Sapien 3 […]

Sahajanand Medical Technology (SMT) announced today that its Hydra TAVR device has received the CE Mark […]

Dive Brief: Transcatheter aortic valve replacement (TAVR) procedures fell around 30% in the U.S. in […]

Before the coronavirus pandemic hit, medtech companies large and small were making notable news with […]

Dive Brief: Edwards Lifesciences on Monday announced it won a CE mark for its Pascal […]

The Irvine, CA-based company said the Pascal repair system demonstrated high procedural success and significant […]

HANGZHOU, China and ATLANTA, May 2, 2020 /PRNewswire/ — Venus Medtech (Hangzhou) Inc. (“Venus Medtech” or the “Company”, together with its […]

Extracardiac temporary pacing technology developer AtaCor Medical announced today that it completed a $25 million Series B […]

Dive Brief: Edwards Lifesciences on Thursday said sales climbed 14% to $1.1 billion in the […]

The United Kingdom today issued a safety notice to warn on the Pilling Clear Advantage […]

Pi-Cardia Ltd. has raised $27 million to develop a catheter-based solution to treat heart valve […]

Abbott (NYSE:ABT) announced today that its TriClip transcatheter tricuspid valve repair system won CE Mark approval […]